RE:RE:RE:RE:RE:RE:RE:Just a thoughtFair enough, yeah your guess is probably correct.
In any event I only got my feet wet with this last spring, and this is the first bio stock I've bought into so I'm certainly learning a lot along the way. These boards have certainly helped me gain insight into what's a typical pathway for these companies. For most of my other investments there isn't the same kind of capital raises and licensing deals, so any speculating I am doing is just that.
I'm still long of course, I believe there is probably a lot of action happening behind the scenes that will only become apparent after the fact, just like the Nuance deal. We 've just got to ride it out!